BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Lung cancer
,
Kidney
,
Pharmacogenetics
,
Rosiglitazone
,
rs2476601
,
MYC
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
peptide I
(compound)
Summary
General Info
Genetic Markers
Most Correlated Genes
No genes found
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
No biogroups found
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
Breast cancer MDA-MB-231 cells with or without cytokine selection
Breast cancer MCF7 cells expressing IGF1R of INSR isoforms IRA or IRB treated with insulin analogues
Bone osteoblast response to treatment with BMP2, TNFa, dexamethasone, vitamin D3, PGE2, or IGF1
Breast cancer cells treated with different concentrations of CXCL12 and IGF1
Expression data from IGFI-stimulated MCF-7 cells
Explore Curated Studies Results
Literature
Most Relevant Literature
Virtual screening and characteristics of novel umami peptides from porcine type I collagen.
Inner residues of macrothiolactone in autoinducer peptides I/IV circumvent spontaneous S-to-O acyl t…
Highly Efficient Cyclization Approach of Propargylated Peptides via Gold(I)-Mediated Sequential C-N,…
Export of diverse and bioactive peptides through a type I secretion system.
Changes in RACK1 expression induce defects in nodulation and development in Phaseolus vulgaris.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
A Phase I In-Vivo Peptide Applied in the Right Colon
A MultIceNTER Phase I Peptide VaCcine Trial for the Treatment of H3-Mutated Gliomas
A Phase I Study to Evaluate LSALT Peptide
Vaccine Combining Multiple Class I Peptides and Montanide ISA 51VG With Escalating Doses of Anti-PD-…
ETAPA I: Peptide-based Tumor Associated Antigen Vaccine in GBM
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ